• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dawn Holcombe Addresses the Continuing Challenges of Defining Evidence and Value in Oncology

Article

Dawn Holcombe, President of DGH Consulting and Executive Director of the Connecticut Oncology Association, discusses how the increasing demand for data and defining evidence and value are so complex that collaboration between payers and providers is critical.

She also addresses her concern for the viability of the oncology market given the uncertainties of additional changes the federal government may make—especially in an election year—and how such changes could negatively impact the delivery of cancer care.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Antonio Urbina, MD
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Tina Bhatnagar, DO
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Antonio Urbina, MD
Ciara Zachary, PhD, MPH
Hearn Jay Cho, MD, PhD
Nicoletta Colombo, MD, PhD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.